Prognostic and therapeutic response prediction in glioblastoma multiforme using a lactylation-associated gene signature
The lactylation-related gene signature established in this study demonstrates robust predictive efficacy in glioblastoma, serving not only as a prognostic biomarker but also offering new directions for personalized treatment strategies.
Authors
- Huan Zhu (ORCID: https://orcid.org/0000-0003-0891-7385)
- Zhigang Liu (ORCID: https://orcid.org/0000-0003-4043-3196)
- Tingting Li (ORCID: https://orcid.org/0000-0001-9209-0602)
- Xuejun Yang (ORCID: https://orcid.org/0000-0001-7056-1223)
- Guanjun Li
- Yifei Li (ORCID: https://orcid.org/0009-0005-6864-7534)
- Yongqin Yang
Institutions
- Jinan University (CN)
- Dongguan People’s Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Chenzhou First People's Hospital (CN)
- First Affiliated Hospital of Jinan University (CN)
- Xiangnan University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1007/s12672-025-04017-6
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00